Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.22B |
| 2 |
Alibaba
BABA
|
+$408M |
| 3 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$292M |
| 4 |
Gilead Sciences
GILD
|
+$218M |
| 5 |
Ford
F
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.37B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$1.18B |
| 3 |
YHOO
Yahoo Inc
YHOO
|
+$619M |
| 4 |
Bank of America
BAC
|
+$487M |
| 5 |
Booking.com
BKNG
|
+$406M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 87.56% |
| 2 | Technology | 2.53% |
| 3 | Consumer Discretionary | 2.02% |
| 4 | Financials | 1.63% |
| 5 | Healthcare | 1.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VSI
8126
PUT
DELISTED
Vitamin Shoppe Inc.
VSI
| $296K | ﹤0.01% |
6,100
-32,500
| -84% | -$1.49M |
|
|
OME
8127
DELISTED
Omega Protein
OME
| $296K | ﹤0.01% |
28,011
+12,682
| +83% | +$150K |
|
8128
Paramount Gold Nevada
PZG
$124M
| $295K | ﹤0.01% |
289,516
+15,247
| +6% | +$11.7K |
|
8129
Rollins
ROL
$17.5B
| $295K | ﹤0.01% |
30,038
-8,100
| -21% | -$75.7K |
|
8130
CALL
TransDigm Group
TDG
$65.6B
| $295K | ﹤0.01% |
1,500
-11,500
| -88% | -$2.17M |
|
8131
Universal Corp
UVV
$1.14B
| $295K | ﹤0.01% |
6,701
-14,498
| -68% | -$611K |
|
|
CBD
8132
CALL
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $295K | ﹤0.01% |
+8,000
| New | +$324K |
|
|
GCAP
8133
PUT
DELISTED
Gain Capital Holdings, Inc.
GCAP
| $295K | ﹤0.01% |
32,700
-19,300
| -37% | -$157K |
|
8134
PUT
MakeMyTrip
MMYT
$5.55B
| $294K | ﹤0.01% |
+11,300
| New | +$309K |
|
8135
CALL
Telecom Argentina
TEO
$5.63B
| $294K | ﹤0.01% |
15,200
+3,900
| +35% | +$81.8K |
|
8136
First Commonwealth Financial
FCF
$2.11B
| $293K | ﹤0.01% |
31,832
-54,257
| -63% | -$488K |
|
8137
PUT
Gentex
GNTX
$4.78B
| $293K | ﹤0.01% |
16,200
-45,200
| -74% | -$751K |
|
8138
CALL
Integra LifeSciences
IART
$1.31B
| $293K | ﹤0.01% |
13,211
-4,159
| -24% | -$84.3K |
|
|
CALA
8139
DELISTED
Calithera Biosciences, Inc
CALA
| $293K | ﹤0.01% |
+726
| New | +$190K |
|
|
SUSQ
8140
PUT
DELISTED
SUSQUEHANNA BANCSHARES INC
SUSQ
| $293K | ﹤0.01% |
21,800
+1,200
| +6% | +$14K |
|
8141
iShares MSCI All Country Asia ex Japan ETF
AAXJ
$3.88B
| $292K | ﹤0.01% |
4,799
-220,025
| -98% | -$13.5M |
|
8142
Lifecore Biomedical
LFCR
$172M
| $292K | ﹤0.01% |
+21,143
| New | +$273K |
|
8143
PUT
Lisata Therapeutics
LSTA
$15.2M
| $292K | ﹤0.01% |
516
-21
| -4% | -$14.3K |
|
8144
PUT
Reading International Class A
RDI
$46M
| $292K | ﹤0.01% |
22,000
+600
| +3% | +$6.53K |
|
8145
Simmons First National
SFNC
$3.28B
| $292K | ﹤0.01% |
14,362
+3,362
| +31% | +$67.6K |
|
|
INVX
8146
CALL
Innovex International
INVX
$2.11B
| $292K | ﹤0.01% |
3,800
-18,000
| -83% | -$1.5M |
|
|
GST
8147
DELISTED
Gastar Exploration Inc.
GST
| $292K | ﹤0.01% |
120,989
-16,377
| -12% | -$59.7K |
|
8148
CALL
ITT
ITT
$18.1B
| $291K | ﹤0.01% |
+7,200
| New | +$301K |
|
8149
Ormat Technologies
ORA
$6.34B
| $291K | ﹤0.01% |
+10,703
| New | +$293K |
|
8150
PUT
Invesco Water Resources ETF
PHO
$2.05B
| $291K | ﹤0.01% |
11,300
+1,900
| +20% | +$48.1K |
|
Similar funds
Jeff Yass's Q4 2014 Portfolio in Review
As of Q4 2014, Jeff Yass held 10,737 positions worth $252B, down 3% from $260B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Jeff Yass's Q4 2014 filing shows 1,370 new, 3,710 increased, 4,352 reduced and 1,178 closed positions. Its largest new stake was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M. The largest sale was iShares MSCI Emerging Markets ETF, an estimated $1.37B.
By sector, the portfolio is most concentrated in Miscellaneous at 88% of assets, up from 87% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2014 buy was Northern Trust Morningstar Global Upstream Natural Resources ETF: 1,011,289 shares worth $31M.
- Jeff Yass added most to State Street SPDR S&P 500 ETF Trust in Q4 2014, an estimated $1.22B increase.
- Jeff Yass's biggest Q4 2014 reduction was iShares MSCI Emerging Markets ETF, cutting an estimated $1.37B.
- Jeff Yass fully exited Bausch Health in Q4 2014, selling an estimated $68.9M.
- Jeff Yass's ten largest holdings make up 23% of its $252B portfolio in Q4 2014.
- Jeff Yass opened 1,370 new positions and closed 1,178 in Q4 2014.
- Jeff Yass's portfolio value fell 3% quarter-over-quarter to $252B.
Based on Susquehanna International Group's 13F filing for Q4 2014, filed 17 Feb 2015.